Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today... Read More

WALTHAM, Mass. / May 12, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. “Following years of... Read More

WALTHAM, Mass. / May 12, 2025 / Business Wire / Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has signed an agreement with UMass Memorial Medical Center intended to support adoption and utilization of its robotic system through enhanced perioperative practices, surgeon education and other... Read More

WALTHAM, Mass. / Apr 28, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the first quarter ended March 31, 2025 after the market closes on Monday, May 12, 2025. Company management will host a corresponding... Read More

WALTHAM, Mass. / Apr 11, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on April 10, 2025, the Company received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating that the Company is no longer in... Read More

WALTHAM, Mass. / Mar 24, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that Company President, Randy Clark, will transition to Board Member, effective April 25, 2025, pending customary conflict checks. As President, Mr. Clark directed critical... Read More

Version 1.0 System Integration Complete; Progressing Towards First Clinical Use Achieved 2024 Cash Burn Guidance; Sets 2025 Cash Burn Guidance of $50 Million WALTHAM, Mass. / Mar 17, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial... Read More

Ms. Romano brings decades of experience with a strong track record in financial strategy and corporate development WALTHAM, Mass. / Mar 13, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer... Read More

WALTHAM, Mass. / Mar 03, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the fourth quarter and fiscal year ended December 31, 2024 after the market closes on Monday, March 17, 2025. Company management will... Read More

WALTHAM, Mass. / Feb 18, 2025 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced Chief Operating Officer (COO) John Mazzola will retire, effective April 1, 2025, after nearly 40 years in healthcare manufacturing, supply chain and quality control. Mr.... Read More

WALTHAM, Mass. / Dec 06, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the... Read More

WALTHAM, Mass. / Nov 12, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter ended September 30, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, November 12, 2024. “Our team's strong... Read More

WALTHAM, Mass. / Oct 29, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the third quarter ended September 30, 2024 after the market closes on Tuesday, November 12, 2024. Company management will host a... Read More

WALTHAM, Mass. / Aug 21, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Management is scheduled to present in a fireside chat on Friday,... Read More

WALTHAM, Mass. / Aug 12, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter ended June 30, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2024. “Our team’s effective... Read More

WALTHAM, Mass. / Aug 07, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has signed a strategic development agreement with the LSU Health New Orleans. LSU Health New Orleans is Louisiana’s flagship and most comprehensive academic health... Read More

WALTHAM, Mass. / Jul 29, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will report financial results for the second quarter ended June 30, 2024 after the market closes on Monday, August 12, 2024. Company management will host... Read More

WALTHAM, Mass. / Jun 10, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will effect a 1-for-30 reverse stock split of the Company’s issued and outstanding Class A common stock, par value $0.0001 per share, and Class B common... Read More

WALTHAM, Mass. / Apr 29, 2024 / Business Wire / Vicarious Surgical Inc . (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced financial results for the quarter ended March 31, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, April 29, 2024. “I’m... Read More

WALTHAM, Mass. / Apr 08, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2024 after the market closes on Monday, April 29, 2024. Company management will host a... Read More

Version 1.0 Surgical System On Track for Cadaveric Testing this Spring Achieves 2023 Cash Burn Objective of $63.4 Million 2024 Cash Burn Guidance of $50 Million Reflects Prior Cost Reduction Initiatives WALTHAM, Mass. / Mar 04, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well... Read More

WALTHAM, Mass. / Feb 20, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will participate in the TD Cowen 44th Annual Healthcare Conference. Management is scheduled to present on Tuesday,... Read More

WALTHAM, Mass. / Feb 12, 2024 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market closes on Monday, March 4, 2024. Company management... Read More

WALTHAM, Mass. / Nov 15, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will present at the Piper Sandler 35th Annual Healthcare Conference. Management is scheduled to participate in a... Read More

WALTHAM, Mass. / Nov 13, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2023. Management will host a corresponding conference call at 4:30 p.m. ET... Read More

WALTHAM, Mass. / Sep 22, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September 20, 2023, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in... Read More

WALTHAM, Mass. / Sep 12, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to enhance patient outcomes and improve the cost and efficiency of surgical procedures, announced it has signed a strategic development agreement with Intermountain Health, a leading U.S. healthcare system. Intermountain Health is a... Read More

WALTHAM, Mass. / Sep 07, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will present at the Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Management is scheduled... Read More

WALTHAM, Mass. / Aug 03, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the Company will participate in the Canaccord Genuity 43rd Annual Growth Conference. Management is scheduled to present on Wednesday,... Read More

WALTHAM, Mass. / Aug 02, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock (“Common Stock”) at a price to the... Read More

WALTHAM, Mass. / Aug 02, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that it has commenced an underwritten public offering of $45.0 million of shares of its Class A common stock (“Common Stock”). All... Read More

WALTHAM, Mass. / Jul 27, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today,... Read More

WALTHAM, Mass. / Jul 13, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter ended June 30, 2023, after the market closes on Thursday, July 27, 2023. Company management will host a... Read More

WALTHAM, Mass. / May 18, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the promotion of John Mazzola to Chief Operating Officer. John joined Vicarious Surgical in March of 2022 as SVP of Operations and... Read More

WALTHAM, Mass. / May 08, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today,... Read More

Fast Company Includes Vicarious Surgical Among the “World Changing Ideas” WALTHAM, Mass. / May 04, 2023 / Business Wire / Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company earned recognition from Fast Company and the MedTech Breakthrough Awards... Read More

WALTHAM, Mass. / Apr 24, 2023 / Business Wire / Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2023, after the market closes on Monday, May 8, 2023. Company management will host a... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in the following upcoming investor conferences. Cowen 43rd Annual Healthcare Conference Fireside Chat on Wednesday, March 8th at 9:50 a.m. ET Oppenheimer 33rd Annual... Read More

Meets Full Year 2022 Cash Burn Objective of $67 Million Announces Cost-Reduction Initiatives to Optimize Cash Burn and Extend Cash Runway Provides Full Year 2023 Cash Burn Guidance of $55-$65 Million Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, 2023. Company management will host a corresponding conference call... Read More

Victoria Carr-Brendel, Ph.D. Elected to Board of Directors Tech-Focused Venture Capitalist Phil Liang to Resign Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23,... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting presentations by representatives... Read More

Surgeon Igor Belyansky, M.D., performs two successful cadaveric ventral hernia repairs using the Beta 2 Vicarious System Highlights to be showcased at Vicarious Surgical’s Beta 2 Demonstration Day on December 6th, 2022 Vicarious Surgical Inc. (“Vicarious Surgical'' or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that renowned... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in the following upcoming investor conferences. 5th Annual Evercore ISI HealthCONx Conference Virtual Fireside Chat on Tuesday, November 29 at 3:05 p.m. ET 34th Annual Piper... Read More

Minimally Invasive Surgical Robotic System Recognized for Innovative Design and Novel Approach Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the outcomes, cost, and efficiency of surgical procedures, today announced their robotic system has been named one of TIME’s Best Inventions of 2022 . The Vicarious Surgical robot was... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, November 7, 2022. “During the third... Read More

Key Partnership Providing Further Support Toward Vicarious System Finalization, Regulatory Submission, and Commercialization Goals Vicarious Surgical Inc. (“Vicarious Surgical'' or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it has signed a collaborative Memorandum of Understanding (“MOU”) agreement with Pittsburgh CREATES,... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the third quarter 2022 after the market closes on Monday, November 7, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.... Read More

Tech-Focused Venture Capitalists Dror Berman and Samir Kaul to Resign Beverly Huss Elected to Board of Directors Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the resignation of technology-focused venture capitalists Dror Berman and Samir Kaul from the Vicarious Surgical Board of... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that it will host a Demonstration Day of its Beta 2 surgical robot prototype for investors and analysts starting at 11:00 a.m. ET on Tuesday, December 6, 2022, at its Waltham, MA headquarters. Further details will be released closer... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Management is scheduled to present on Wednesday, August... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, August 8, 2022. “We are excited to step closer... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in the Canaccord Genuity 42nd Annual Growth Conference. Management is scheduled to present on Wednesday, August 10 at 9:30 a.m. ET. A live webcast of the... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter 2022 after the market closes on Monday, August 8, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it has signed collaborative Center of Excellence (“COE”) agreements with both HCA Healthcare, one of the nation’s leading providers of healthcare services comprising 182 hospitals, and University Hospitals Ventures, the innovation and... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced it is set to join the broad-market Russell 3000® Index as well as the Russell 2000® and Russell Microcap® Indexes at the conclusion of the 2022 Russell indexes annual reconstitution,... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in a virtual fireside chat at the Cowen 7th Annual FutureHealth Conference. Management is scheduled to present on Wednesday, June 22 at 10:50 a.m. ET. A... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, May 9, 2022. “We have made measurable progress... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter 2022 after the market closes on Monday, May 9, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.... Read More

Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced qualification of its cleanroom for manufacturing of the Vicarious System. The cleanroom substantially augments the company’s existing capabilities by providing an environmentally controlled and easily expandable space for precision... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as the cost and efficiency of surgical procedures, today announced the appointment of John Mazzola as vice president of operations. In this new role, Mazzola will lead the strategic manufacturing plans for the Vicarious system as the company... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced its preliminary unaudited fourth quarter and full year 2021 financial results. “2021 was an incredible year at Vicarious Surgical. I want to congratulate our team and thank our... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced that the company will be participating in the following virtual investor conferences. Cowen 42 nd Annual Healthcare Conference Presentation on Tuesday, March 8, at 9:10 a.m. ET... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced it will report financial results for the fourth quarter 2021 after the market closes on Thursday, March 3, 2022. Company management will host a corresponding conference call beginning... Read More

Vicarious Surgical is proud to announce it has been honored with three awards from Built In’s 2022 Best Places To Work Awards. Specifically, Vicarious Surgical earned a place in the following three categories in Boston: Best Places to Work, Best Midsize Companies to Work for, and Best Paying Companies. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors companies in the... Read More

Vicarious Surgical (NYSE: RBOT, RBOT WS) announces it has won the MedTech Powerhouse Company of the Year Award at the 2021 NEVY Awards , hosted by the New England Venture Capital Association (NEVCA). The theme this year highlighted the “heroes” of New England’s innovation ecosystem—the entrepreneurs and investors committed to leveraging science and technology for a better tomorrow. “It is an honor to be named MedTech... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in a fireside chat at the upcoming Piper Sandler 33 rd Annual Virtual Healthcare Conference. A recording of the presentation will be available beginning... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced third quarter 2021 financial results. “This quarter marks our entry into the public markets, and I am incredibly proud of our teams and employees for their contributions to our... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. Management is scheduled to present on Thursday, November 18 th at... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced that management will participate in the Credit Suisse 30 th Annual Healthcare Conference. Management is scheduled to present on Thursday, November 11 th at 3:30 p.m. Eastern Time and... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced it will report financial results for the third quarter 2021 after the market closes on Monday, November 8, 2021. Company management will host a corresponding conference call beginning... Read More

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced execution on a long term lease agreement providing an additional 30,000 square feet in Waltham, MA. The new facility will expand manufacturing facilities and include four operating... Read More